Hosted on MSN3mon
Maze Therapeutics raises $115m to advance kidney disease candidatesMaze Therapeutics has completed a Series D financing round, raising $115m to propel the development of its lead candidates, MZE829 and MZE782. The financing round included the conversion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback